CVS Health Corporation

CVS.F·Frankfurt·Healthcare
Compare
84.04+0.38 (+0.45%)today
As of Oct 23, 8:02 AM CEST · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close83.66
Open84.04
Day range—
52-week range60.1696.66
Off day high0.00%
Off 52-week high−13.06%
Volume15.00
Avg. volume (3M)41.00
Market cap107.48B
EPS (TTM)3.26
Forward P/E—
P/E ratio (TTM)25.78
Dividend yield2.81% (2.37)
Beta (5Y)0.60
Shares outstanding1.28B
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin1.18%

Against its peers

Compare in full ›
CVS.F CI HUM ELV UNH CNC
Market cap 107.48B 81.11B 50.68B 95.41B 375.28B 34.66B
P/E (TTM) 25.8 12.7 39.9 18.7 26.9 —
Forward P/E — 9.2 24.7 14.6 18.0 13.1
Price/book 1.5 1.9 2.6 2.1 3.6 1.5
Dividend yield 2.81% 1.98% 0.84% 1.55% 2.18% —
1-year change +20.06% +4.67% +44.84% +30.07% +17.24% +109.10%
Today +0.45% −2.83% +0.26% −1.20% −1.62% −1.50%

The closest companies by business and industry (Healthcare Plans). Prices may be delayed up to 15 min.

Latest news

All CVS.F news ›
TokenPost·Positive

Strategist Highlights $82-$86 Range for CVS Health Shares

Jay Woods estimated a 15% year-to-date gain for the health care sector and identified $110 as a possible resistance test for CVS shares. Freedom Capital Markets Chief Market Strategist Jay Woods singled out the $82-to-$86 range as a test…

CBS News·Negative

CVS Health agrees to $5 billion settlement of opioid lawsuits

November 2, 2022 / 7:08 AM EDT / CBS/AP Two of the largest U.S. pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids,…

Defense World·Positive

CVS Health Corporation $CVS Stock: SteelPeak Wealth LLC Raises Stake

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. The ex-dividend date of this dividend is…

zacks.com·

Pardon Our Interruption

Boston Scientific's Q3 results hinge on MedSurg strength in Endoscopy and Neuromodulation, as Cardiovascular faces competitive pressures and softer sales. As you were browsing something about your browser made us think you were a bot.…

From articles in the 4Search news index.

In the news

283mentions in 30 days
83with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.